Potential of IL-1, IL-18 and Inflammasome Inhibition for the Treatment of Inflammatory Skin Diseases.
about
Melatonin as an Anti-Inflammatory Agent Modulating Inflammasome Activation.Pharmacological Regulation of Neuropathic Pain Driven by Inflammatory Macrophages.NLR-Dependent Regulation of Inflammation in Multiple Sclerosis- Dependent Regulation of Inflammation in Multiple Sclerosis.Subcutaneous administration of a Neutralizing IL-1β antibody prolongs limb allograft survival.Immunomodulation to Prevent or Treat Neonatal Sepsis: Past, Present, and FutureIL-6, IL-17 and Stat3 are required for auto-inflammatory syndrome development in mouseIs IL-1β Further Evidence for the Role of in Degenerative Disc Disease? Lessons From the Study of the Inflammatory Skin Condition Acne Vulgaris
P2860
Q47098709-C1796B70-B095-459B-BF2C-5B81B669AFB8Q47101484-FB3A7FD4-7D0D-47EF-82DD-1D391E0E1159Q49516622-22F8D9CE-7D3C-4AAD-8272-4049CEA826BCQ52720398-83580061-D7CD-4097-97BE-C24CC0D64C63Q57175340-DBE3D325-10BF-4AB9-883E-E9BB79BB9E0DQ58562869-CAC7E4B5-0B1A-481A-A0AD-8219948DF059Q58781062-5E729927-4174-4B9B-A5D5-D8DE2729E02F
P2860
Potential of IL-1, IL-18 and Inflammasome Inhibition for the Treatment of Inflammatory Skin Diseases.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Potential of IL-1, IL-18 and I ...... of Inflammatory Skin Diseases.
@ast
Potential of IL-1, IL-18 and I ...... of Inflammatory Skin Diseases.
@en
type
label
Potential of IL-1, IL-18 and I ...... of Inflammatory Skin Diseases.
@ast
Potential of IL-1, IL-18 and I ...... of Inflammatory Skin Diseases.
@en
prefLabel
Potential of IL-1, IL-18 and I ...... of Inflammatory Skin Diseases.
@ast
Potential of IL-1, IL-18 and I ...... of Inflammatory Skin Diseases.
@en
P2860
P356
P1476
Potential of IL-1, IL-18 and I ...... of Inflammatory Skin Diseases
@en
P2093
Emmanuel Contassot
P2860
P356
10.3389/FPHAR.2017.00278
P577
2017-05-22T00:00:00Z